REQUEST A DEMO
Total
USD $0.00
Search more companies

Broxtonium Invest S.R.O. (Czech Republic)

Main Activities: General Medical and Surgical Hospitals
Full name: Broxtonium Invest S.R.O. Profile Updated: November 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Broxtonium Invest S.R.O. is based in Czech Republic. The head office is in Olomouc. It operates in the General Medical and Surgical Hospitals industry. The company was established on May 19, 2011. There are currently 6 - 9 (2024) people employed by Broxtonium Invest S.R.O.. The company’s latest financial report indicates a net sales revenue increase of 8.76% in 2023. During that time, Broxtonium Invest S.R.O.’s total assets grew by 28.47%. Broxtonium Invest S.R.O.’s net profit margin decreased by 6.3% in 2023.

Headquarters
Palackeho 626/3
Olomouc; Olomoucky; Postal Code: 77900

Contact Details: Purchase the Broxtonium Invest S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Broxtonium Invest S.R.O. report to view the information.
Outstanding Shares:
Purchase the Broxtonium Invest S.R.O. report to view the information.
Registered Capital:
Purchase the Broxtonium Invest S.R.O. report to view the information.
Incorporation Date:
May 19, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Broxtonium Invest S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
8.76%
Total operating revenue
8.72%
Operating profit (EBIT)
-21.53%
EBITDA
-4.62%
Net Profit (Loss) for the Period
-28.05%
Total assets
28.47%
Total equity
6.16%
Operating Profit Margin (ROS)
-6.37%
Net Profit Margin
-6.3%
Return on Equity (ROE)
-9.94%
Quick Ratio
-3.25%
Cash Ratio
-3.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?